KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Total Non-Current Liabilities (2019 - 2025)

Historic Total Non-Current Liabilities for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $717.2 million.

  • GoodRx Holdings' Total Non-Current Liabilities rose 1040.54% to $717.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $717.2 million, marking a year-over-year increase of 1040.54%. This contributed to the annual value of $656.7 million for FY2024, which is 1978.97% down from last year.
  • As of Q3 2025, GoodRx Holdings' Total Non-Current Liabilities stood at $717.2 million, which was up 1040.54% from $668.6 million recorded in Q2 2025.
  • GoodRx Holdings' 5-year Total Non-Current Liabilities high stood at $818.9 million for Q3 2023, and its period low was $634.0 million during Q1 2025.
  • In the last 5 years, GoodRx Holdings' Total Non-Current Liabilities had a median value of $767.5 million in 2022 and averaged $750.0 million.
  • Within the past 5 years, the most significant YoY rise in GoodRx Holdings' Total Non-Current Liabilities was 1040.54% (2025), while the steepest drop was 2216.27% (2025).
  • GoodRx Holdings' Total Non-Current Liabilities (Quarter) stood at $770.6 million in 2021, then increased by 1.52% to $782.2 million in 2022, then rose by 4.66% to $818.7 million in 2023, then fell by 19.79% to $656.7 million in 2024, then increased by 9.23% to $717.2 million in 2025.
  • Its Total Non-Current Liabilities was $717.2 million in Q3 2025, compared to $668.6 million in Q2 2025 and $634.0 million in Q1 2025.